2026 SSC Children Guidelines Updates: What Clinicians Need to Know-Surviving Sepsis Campaign Children's Guidelines: 2026 Update

Surviving Sepsis Campaign Children's Guidelines: 2026 Update - Handouts

Pdf Summary

The document summarizes a Society of Critical Care Medicine (SSC) webinar (April 7, 2026) on the 2026 SSC Children’s Sepsis Guidelines updates, focusing on hemodynamic resuscitation, adjunct therapies, and follow-up. The guideline process used GRADE (strong vs conditional recommendations and good practice statements). The panel noted major evidence limitations: 27 of 29 recommendations are based on low/very low certainty, and for 22 topics the panel could issue no recommendation or only a good practice statement.

<strong>Hemodynamic resuscitation and fluids:</strong> For septic shock with ICU available, clinicians should give up to 40–60 mL/kg bolus fluids (10–20 mL/kg per bolus) in the first hour; in settings without ICU, fluid boluses are discouraged for sepsis without hypotension, but suggested up to 40 mL/kg for hypotensive septic shock. Reassess after each bolus and stop if shock resolves or fluid overload develops. Crystalloids are preferred over albumin; balanced/buffered crystalloids are suggested over 0.9% saline due to similar mortality but possible lower AKI/RRT.

<strong>Monitoring:</strong> Ongoing bedside clinical assessment remains central. Evidence was insufficient to define optimal MAP percentile targets. When central access is available, targeting ScvO₂ 70% is suggested. Evidence is insufficient for “advanced” hemodynamic monitoring, but cardiac/lung POCUS is suggested where training/resources allow, with small trials showing faster shock reversal and shorter ICU stay.

<strong>Vasoactives:</strong> Evidence is insufficient on starting vasoactives before vs after 40 mL/kg fluids and on choosing epinephrine vs norepinephrine first-line. Starting vasoactives via peripheral IV rather than waiting for central access is suggested, with observational data indicating low extravasation risk and possible mortality benefit. For high-dose catecholamines, adding vasopressin or further titrating catecholamines is suggested; evidence is insufficient for inodilators, angiotensin II, or methylene blue.

<strong>Adjunct therapies and follow-up:</strong> New/updated items include a conservative post-resuscitation oxygen target (SpO₂ 88–92%) for intubated children (moderate certainty), continued avoidance of etomidate, and insufficient evidence on intubation absent respiratory failure. Hydrocortisone is suggested against when stability is achievable with fluids/vasopressors; refractory shock has insufficient evidence. Fever management and bicarbonate for metabolic acidemia also have insufficient evidence. Vitamins C, thiamine, and routine vitamin D repletion are suggested against. Post-resuscitation fluid overload prevention and active removal earned a good practice statement. A major direction change: high-volume hemofiltration is now suggested for septic children requiring RRT. A new post-ICU section highlights frequent long-term morbidity, suggesting early rehab bundles and recommending risk assessment, education, and evaluation for post-sepsis sequelae.

Keywords

2026 SSC Children’s Sepsis Guidelines

pediatric septic shock

hemodynamic resuscitation

fluid bolus 40–60 mL/kg first hour

balanced crystalloids vs normal saline

ScvO2 target 70%

point-of-care ultrasound (POCUS) monitoring

peripheral vasoactive infusion

vasopressin for catecholamine-refractory shock

post-sepsis follow-up and rehabilitation

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.